Menu Menu


Scroll down for graphs: click for enlarged view

Per of global
  • Global ophthalmology trial for uveitis
  • India started 12 months after other global sites
  • Currently India has the maximal contribution towards the global patient pool
  • The ratio of sites in India vs RoW was 1:3
  • Project and site specific referral and recruitment strategies were utilized
enr total
  •  Global ophthalmology trial for uveitis
  •  Site identification done by ELS
  •  Average enrollment per site was the highest from the Indian sites
  •  This was largely contributed by the presence of trained CRC at site
Open Queries
  •  Global ophthalmology trial for uveitis
  •  With maximal enrolment globally ELS operations team managed to keep the  open queries at a minimum
  •  Query resolution turn-around time was within 48 hours
  •  Dedicated ELS resources at each site resolve queries within timeline
Visits Completed
  •  Total number of screening, randomization, follow up  and unscheduled visits completed by ELS team till  date
  •  This includes trials for all therapeutic areas
  •  All protocol defined activities were completed on time during these visits
  •  96% of these visits were on schedule or within the window period